Glenmark Pharmaceuticals Europe Limited

General information

Name:

Glenmark Pharmaceuticals Europe Ltd

Office Address:

2-b Laxmi House Draycott Avenue Kenton HA3 0BU Harrow

Number: 05040260

Incorporation date: 2004-02-10

End of financial year: 31 March

Category: Private Limited Company

Status: Active

Description

Data updated on:

This firm called Glenmark Pharmaceuticals Europe was created on 2004-02-10 as a Private Limited Company. The company's headquarters can be reached at Harrow on 2-b Laxmi House, Draycott Avenue Kenton. When you want to contact the business by post, its area code is HA3 0BU. The company reg. no. for Glenmark Pharmaceuticals Europe Limited is 05040260. Previously Glenmark Pharmaceuticals Europe Limited switched it’s listed name three times. Up to 2013-11-29 this firm used the registered name Glenmark Generics (europe). Later on this firm used the registered name Glenmark Pharmaceuticals (europe) which was in use until 2013-11-29 when the final name was adopted. The company's registered with SIC code 46460: Wholesale of pharmaceutical goods. 31st March 2022 is the last time the accounts were filed.

According to the latest update, there’s only a single managing director in the company: Oliver B. (since 2015-03-15). Since July 2017 Achin G., had performed assigned duties for the business till the resignation on 2021-08-20. What is more another director, specifically Alexandra P. gave up the position 8 years ago.

  • Previous company's names
  • Glenmark Pharmaceuticals Europe Limited 2013-11-29
  • Glenmark Generics (europe) Limited 2007-11-26
  • Glenmark Pharmaceuticals (europe) Limited 2006-09-14
  • Glenmark Pharmaceuticals (UK) Ltd 2004-02-10

Company staff

Oliver B.

Role: Director

Appointed: 15 March 2015

Latest update: 16 March 2024

People with significant control

Executives who have control over this firm are as follows: Blanche S. owns 1/2 or less of company shares. Cherylann P. owns 1/2 or less of company shares. Glenn S. has substantial control or influence over the company.

Blanche S.
Notified on 6 April 2016
Nature of control:
1/2 or less of shares
Cherylann P.
Notified on 6 April 2016
Nature of control:
1/2 or less of shares
Glenn S.
Notified on 6 April 2016
Nature of control:
substantial control or influence

Accounts Documents

Account next due date 31 December 2023
Account last made up date 31 March 2022
Confirmation statement next due date 22 February 2024
Confirmation statement last made up date 08 February 2023

Company filings

Filing category

Hide filing type
Accounts Address Annual return Capital Change of name Confirmation statement Incorporation Mortgage Officers Persons with significant control Resolution
Free Download
Full accounts data made up to Friday 31st March 2023 (AA)
filed on: 20th, December 2023
accounts
Free Download Download filing (28 pages)

Search other companies

Services (by SIC Code)

  • 46460 : Wholesale of pharmaceutical goods
20
Company Age

Similar companies nearby

Closest companies